Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 August 2025 | Story Martinette Brits | Photo Stephen Collett
Prof Willem Boshoff
Prof Willem Boshoff shares insights from decades of rust disease research during his inaugural lecture at the University of the Free State.

Rust diseases of food crops remain one of agriculture’s most enduring and evolving challenges. In his inaugural lecture on 23 July 2025 at the University of the Free State (UFS), Prof Willem Boshoff shared how these complex pathogens continue to pose a significant threat to South Africa’s staple crops – and why continued research is more critical than ever.

Titled Battling rust diseases of food crops in South Africa, the lecture reflected on decades of rust research and recent developments in pathogen virulence. Prof Boshoff, from the Department of Plant Sciences, emphasised that the threat posed by rust fungi today stems from their “mechanisms of variability, their ease of long-distance spore dispersal, and subsequent foreign race incursions”.

 

A shifting disease landscape

Rust fungi are biotrophic organisms that cannot be cultured on artificial growth media. This makes rust research a technically demanding field that requires living pathogen collections, seed sources, skilled researchers, and specialised infrastructure. Prof Boshoff noted that for more than 35 years, the UFS has been at the forefront of this work, monitoring rust pathogens on wheat, barley, oats, maize, and sunflower.

While wheat remains the most extensively studied type, recent rust outbreaks across a range of crops point to a worrying trend. A localised outbreak of stem rust on spring wheat in the Western Cape has been linked to race BFGSF, which carries a previously unknown combination of virulence genes affecting both wheat and triticale. In 2021, leaf rust race CNPSK was detected, showing virulence to the highly effective Lr9 resistance gene.

More recently, stripe rust race 142E30A+ – first reported in Zimbabwe – was found in wheat cultivars from the Free State and northern irrigation areas. “Results revealed increased susceptibility of especially spring irrigation wheat cultivars,” Prof Boshoff explained, particularly due to its virulence to the Yr9 and Yr27 resistance genes.

Rust pathogens affecting other crops are also evolving. In maize, only a few lines with mostly stacked resistance gene combinations were effective against all tested isolates. In sunflower, just four of 30 Agricultural Research Council national trial hybrids showed resistance to local rust races.

 

Building better resistance

A key strategy in rust control lies in identifying and understanding resistance in host plants. This, Prof Boshoff stressed, requires optimised phenotyping systems for both greenhouse and field conditions, along with a solid understanding of available resistance sources. At the UFS, several recent studies have contributed valuable data to both local and international plant breeding programmes.

“Continued local and regional rust research is critical,” he said. “It supports early detection of new races, alerts to producers through updated cultivar responses, and enables efficient breeding strategies and other sustainable methods of rust management.”

The rust programme at the UFS has not only supported varietal release and on-farm risk management, but also strengthened collaboration between plant scientists, industry partners, and international researchers. With South Africa’s strategic location and history of rust surveillance, the programme continues to play a pivotal role in continental and global food security efforts.

 

About Prof Willem Boshoff

Prof Willem Boshoff is a plant pathologist with a strong background in wheat breeding and rust disease control. He holds four degrees from the University of the Free State, all awarded cum laude: a BScAgric (1994), BScAgric Honours (1995), MScAgric (1997), and PhDAgric (2001). His doctoral research focused on the control of foliar rusts in wheat.

Between 2001 and 2016, he worked as a wheat breeder and contributed to the release of several commercial cultivars. He joined the UFS Department of Plant Sciences in 2017 and has since been actively involved in national and international research projects, capacity development, and advancing disease resistance in food crops.

News Archive

Research contributes to improving quality of life for cancer patients
2016-11-21

Description: Inorganic Chemistry supervisors  Tags: Inorganic Chemistry supervisors

Inorganic Chemistry supervisors in the Radiopharmacy
Laboratory during the preparation of a typical complex
mixture to see how fast it reacts. Here are, from the left,
front: Dr Marietjie Schutte-Smith, Dr Alice Brink
(both scholars from the UFS Prestige
Scholar Programme), and Dr Truidie Venter (all three
are Thuthuka-funded researchers).
Back: Prof André Roodt and Dr Johan Venter.
Photo: Supplied

Imagine that you have been diagnosed with bone cancer and only have six months to live. You are in a wheelchair because the pain in your legs is so immense that you can’t walk anymore – similar to a mechanism eating your bones from the inside.

You are lucky though, since you could be injected with a drug to control the pain so effective that you will be able to get out of the wheelchair within a day-and-a-half and be able to walk again. Real-life incidents like these provide intense job satisfaction to Prof André Roodt, Head of Inorganic Chemistry at the University of the Free State (UFS). The research, which is conducted by the Inorganic Group at the UFS, contributes greatly to the availability of pain therapy that does not involve drugs, but improves the quality of life for cancer patients.

The research conducted by the Inorganic Group under the leadership of Prof Roodt, plays a major role in the clever design of model medicines to better detect and treat cancer.

The Department of Chemistry is one of approximately 10 institutions worldwide that conducts research on chemical mechanisms to identify and control cancer. “The fact that we are able to cooperate with the Departments of Nuclear Medicine and Medical Physics at the UFS, the Animal Research Centre, and other collaborators in South Africa and abroad, but especially the methodology we utilise to conduct research (studying the chemical manner in which drugs are absorbed in cancer as well as the time involved), enhances the possibility of making a contribution to cancer research,” says Prof Roodt.

Technique to detect cancer spots on bone
According to the professor, there are various ways of detecting cancer in the body. Cancer can, inter alia, be identified by analysing blood, X-rays (external) or through an internal technique where the patient is injected with a radioactive isotope.

Prof Roodt explains: “The doctor suspects that the patient has bone cancer and injects the person with a drug consisting of an isotope (only emits X-rays and does no damage to tissue) that is connected to a phosphonate (similar to those used for osteoporosis). Once the drug is injected, the isotope (Technetium-99m) moves to the spot on the bone where the cancer is located. The gamma rays in the isotope illuminate the area and the doctor can see exactly where treatment should be applied. The Technetium-99m has the same intensity gamma rays as normal X-rays and therefore operates the same as an internal X-ray supply.” With this technique, the doctor can see where the cancer spots are within a few hours.

The same technique can be used to identify inactive parts of the brain in Alzheimer patients, as well as areas of the heart where there is no blood supply or where the heart muscle is dead.

Therapeutic irradiation of cancer
For the treatment of pain connected with cancer, the isotope Rhenium-186 is injected. Similar to the manner in which the Technetium-99m phosphonate compound is ingested into the body, the Rhenium-186 phosphonate travels to the cancer spots. Patients thus receive therapeutic irradiation – a technique known as palliative therapy, which is excellent for treating pain. A dosage of this therapy usually lasts for about two months.

The therapy is, however, patient specific. The dosages should correspond with the occurrence and size of cancer spots in the patient’s body. First, the location of the cancer will be determined by means of a technetium scan. After that, the size of the area where the cancer occurs has to be determined. The dosage for addressing total pain distribution will be calculated according to these results.

Technique to detect cancer spots on soft tissue
Another technique to detect cancer as spots on bone or in soft tissue and organs throughout the body is by utilising a different type of irradiation, a so-called PET isotope. The Fluor-18 isotope is currently used widely, and in Pretoria a machine called a cyclotron was produced by Dr Gerdus Kemp, who is a former PhD graduate from the Inorganic Research Group. The F-18 is then hidden within a glucose molecule and a patient will be injected with the drug after being tranquillised and after the metabolism has been lowered considerably. The glucose, which is the ‘food' that cancer needs to grow, will then travel directly to the cancer area and the specific area where the cancer is located will thus be traced and ‘illuminated’ by the Fluor-18, which emits its own 'X-rays'.

In the late 80s, Prof Roodt did his own postdoctoral study on this research in the US. He started collaborating with the Department of Nuclear Medicine at the UFS in the early 90s, when he initiated testing for this research.

Through their research of more than 15 years, the Inorganic Group in the Department of Chemistry has made a major contribution to cancer research. Research on mechanisms for the detection of cancer, by designing new clever chemical agents, and the chemical ways in which these agents are taken up in the body, especially contributes to the development in terms of cancer therapy and imaging, and has been used by a number of hospitals in South Africa.

The future holds great promise
Prof Roodt and his team are already working on a bilateral study between the UFS and Kenya. It involves the linking of radio isotopes, as mentioned above, to known natural products (such as rooibos tea), which possess anti-cancer qualities.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept